drugset / Trial / NCT03055078

Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Aplastic Anemia

NCT03055078

Phase 1 Unknown 10 enrolled Hebei Medical University
NaSingle-groupOpen-labelTreatment

Summary

This study is to evaluate the safety and efficacy of Umbilical Cord Derived Mesenchymal Stem Cells transplantation in aplastic anemia.

Timeline

Start
2017-01
Primary completion
2018-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 1e+08 cells Intravenous
Subject mesenchymal stem cells Cell therapy 3e+08 cells Intravenous

Indications